ABSTRACT
Cancer in children is a rare and life-threatening disease. Improvements in survival have only been possible through the development of long and aggressive treatment protocols. As described earlier, the increasing success of these treatments is evident in improved survival rates for many childhood cancers. With these improvements in survival rates comes the luxury of considering quality, as well as quantity of survival.
